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Distal tubule bicarbonate reabsorption in intact and remnant Although there is evidence that steroid hormones can
diabetic kidneys. increase the rates of acid excretion in the adrenal insuffi-
Background. In the diabetic patient, hyperkalemia and hy- cient human, it is unclear whether these responses haveperchloremic metabolic acidosis has been attributed to one or
been independent of potassium lowering effects [5, 6].more of the following factors associated with diabetic nephrop-
Although some studies suggest that hyperkalemia, ratherathy: hypoaldosteronism, altered potassium homeostasis, or a
distal tubular (DT) defect in hydrogen ion secretion. To evalu- than a direct tubular effect of mineralocorticoids, ac-
ate maximal in vivo DT acidification in streptozotocin (STZ) counts entirely for the corrective acid-base response [7],
diabetes, unidirectional bicarbonate reabsorption (JHCO3) was even the early report of Pe´rez et al shows that despitemeasured in DTs after acid loading and in surviving DT after
10 days of deoxycorticosterone acetate (DOCA) admin-2/3 nephrectomy (Nx).
istration and normalization of serum potassium concen-Methods. Acid gavage induced hyperchloremic metabolic
acidosis in four groups of rats: diabetic rats with hyperglycemia tration, a renal acidifying defect persisted, including bi-
two (a) and (b) eight weeks after STZ injection, (c) diabetic carbonaturia when plasma bicarbonate was normal [6].
rats with tight glucose control two weeks after STZ injection Thus, in the diabetic patient with hyperkalemia and met-
and insulin pump implantation; and (d) control nondiabetic
abolic acidosis, the acidification defect may be attributedrats. Another group of diabetic rats underwent (e) Nx one
to one or more of the following: (a) hypoaldosteronism,week after STZ injection; these rats were neither acid loaded
nor pump implanted. (b) hyperkalemia, and (c) a tubular defect associated
Results. In the acidotic rats, the plasma potassium concentra- with diabetic nephropathy.
tion, the plasma and urine acid-base parameters in the three Accordingly, our present studies were designed to
STZ diabetic groups was not different from control rats,
evaluate the possible role of impaired distal tubule (DT)whereas JHCO3 fluxes were brisk without important differences
acidification. We determined in vivo and in the absencebetween groups. In Nx rats, although the plasma potassium
concentration and acid-base status were normal, surviving of hyperkalemia whether or not DT bicarbonate reab-
JHCO3 fluxes were still brisk and not different from the acid- sorption proceeds normally in (a) streptozotocin (STZ)
loaded rats. diabetic rats after acid loading with and without concomi-
Conclusions. These in vivo measurements indicate there is
tant hyperglycemia, and (b) whether or not survivingno impairment in DT unidirectional bicarbonate reabsorption
DTs from STZ diabetic rats after 2/3 nephrectomy (NX)in the intact or remnant STZ diabetic kidney.
enhance bicarbonate reabsorption in the absence of an
acid load, as described in nondiabetic animals. Our re-
sults demonstrate, to our knowledge for the first time,Diabetic patients, in the absence of ketoacidosis, may
that there is no impairment in DT bicarbonate reabsorp-present with hyperchloremic metabolic acidosis associ-
tion in the intact or remnant STZ diabetic kidney.ated with hyperkalemia and hypoaldosteronism. This
syndrome has been designated as type IV renal tubular
acidosis (RTA) [1, 2], and is probably the most common METHODS
acidification defect in patients with diabetic nephropathy
Adult male Sprague-Dawley rats from Charles Riverand reduced creatinine clearance [3–5].
Canada (St. Constant, Quebec, Canada) weighing be-
tween 225 and 250 g were fed a standard laboratory rat
chow (diet 5012; Ralston Purina of Canada, Woodstock,Key words: streptozotocin diabetes, acid-base balance, RTA, meta-
bolic acidosis, bicarbonaturia. Ontario, Canada) and had free access to tap water.
After anesthesia with halothane and 100% oxygen, 5Received for publication January 28, 1999
mL of Normosol R (Abbott Laboratories, Saint-Laurent,and in revised form August 9, 1999
Accepted for publication September 8, 1999 Quebec, Canada) were injected intravenously into the
dorsal tail vein, followed by a slow bolus over two toÓ 2000 by the International Society of Nephrology
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Table 1. Experimental protocols
Group Pretreatment Infusion
1. Diabetic, hyperglycemic, meta- STZ i.v., 15 days insulin injections, 2% body wt 2% body wt/h donor plasma (0.5 h), 2% body wt/h
bolic acidosis gavage 2 N NH4Cl (18 h pre-exp) of 0.05 N HCl in saline
2. Diabetic, hyperglycemic, meta- STZ i.v., 60 days insulin injections, 2% body wt 2% body wt/h donor plasma (0.5 h), 2% body wt/h
bolic acidosis gavage 2 N NH4Cl (18 h pre-exp) of 0.05 N HCl in saline
3. Diabetic, normoglycemic, meta- STZ i.v., 15 days insulin pump, 2% body wt ga- 2% body wt/h donor plasma (0.5 h), 2% body wt/h
bolic acidosis vage 2 N NH4Cl (18 h pre-exp) of 0.05 N HCl in saline
4. Diabetic, hyperglycemic, 2/3 Nx STZ i.v., 7 days of insulin injections, then 2/3 Nx, 1% body wt/h donor plasma (0.5 h), 1% body wt/h
12–14 days of insulin injections post-surgery of 0.9% saline
5. Non-diabetic, metabolic acidosis 2% body wt gavage 2 N NH4Cl (18 h pre-exp) 2% body wt/h donor plasma (0.5 h), 2% body wt/h
of 0.05 N HCl in saline
three minutes of 65 mg/kg of STZ (Sigma, St. Louis, Balance, microperfusion techniques, and
analytical methodsMO, USA) dissolved in 0.1 mol/L sodium citrate buffer
(pH 4.0). The next day, the onset of diabetes was deter- Rats were housed in individual stainless steel meta-
mined by the presence of hyperglycemia and glycosuria. bolic cages for 18 hours (overnight) prior to microperfu-
sion, allowing the measurement of ingested food and
Experimental groups drink and the collection of urine under oil, using thymol
as a preservative. The following morning, the animalsAs shown in Table 1, STZ rats were divided into four
were anesthetized with 100 mg/kg thiobutabarbital so-groups. Group 1 (STZ-2 week 1 NH4Cl) and group 2
dium (Inactin; Research Biochemical International, Na-(STZ-8 week 1 NH4Cl) both received daily Humulin
tick, MA, USA) and prepared for microperfusion, asLente insulin (Eli Lily & Co., Indianapolis, IN, USA)
described previously [8]. Briefly, the rat was placed oninjections for two and eight weeks, respectively. Group
a heated operating table, and a tracheostomy was per-3 (STZ 1 PUMP 1 NH4Cl) had an insulin pump implant
formed using PE-240 tubing. The left carotid artery was(LinShin Canada, Scarborough, Ontario, Canada). These
cannulated for continuous blood pressure measurementthree groups of rats were gavaged with ammonium chlo-
and the collection of blood for acid-base and electrolyteride (2 N NH4Cl at 2% body weight) 18 hours before
analyses, whereas the left jugular vein was cannulatedexperimentation to induce metabolic acidosis, thereby
with three lines for infusion of fluid, pentobarbital so-stimulating DT proton secretion and bicarbonate reab-
dium anesthetic (Somnotol; MTC Pharmaceuticals,sorption. Group 4 (STZ 1 2/3 Nx) was subjected to renal
Cambridge, Ontario, Canada), and 10% Lissamine green.ablation and received daily insulin injections but was not
The left kidney was exposed by flank incision, carefullygavaged. Group 5 (normal 1 NH4Cl) was comprised of
dissected from the adrenal gland, and immobilized in anormal rats, not treated with STZ, but gavaged with
stainless steel cup covered with mineral oil. The ureterNH4Cl. was catheterized with PE-50 tubing to ensure the proper
urine flow.Insulin administration
All groups were infused with donor plasma from nor-
After the onset of diabetes, groups 1 and 2 received mal rats for 30 minutes at 2% body weight/hour to re-
a once-daily injection of two units of insulin administered place surgical fluid losses, with the exception of group 4
subcutaneously for two and eight weeks, respectively. rats, which were infused for 30 minutes at 1% body
This was sufficient to prevent ketosis but allowed hyper- weight/hour (Table 1). For the duration of the experi-
glycemia to persist. Group 3 rats received an insulin ment, groups 1, 2, 3, and 5 rats were infused with 0.05
pellet implant designed to deliver two units of insulin N HCl in 0.9% saline at 2% body weight/hour, whereas
per day to provide tight glycemic control. Group 4 rats, group 4 rats were infused with 0.9% saline at 1% body
after seven days of diabetes and daily insulin injections weight/hour.
as for group 1, underwent right NX and polectomy of Perfusable surface two-loop DTs were identified by
the left kidney, resulting in approximately 2/3 Nx, as injecting a 0.02 mL bolus of 1% Lissamine green
recently described by this laboratory [8]. These Nx rats (Steinhausen) into surface proximal loops and observing
required on average only one unit of insulin daily. They its passage through the nephron. DT were perfused
were allowed to recover for 13 to 16 days after Nx so at 20 nL/min with hypotonic solution containing (in
that the interval between the onset of diabetes and the mmol/L): 15 HCO3, 0 Cl, 56 Na, 2 K, 1.8 Ca, 16.6 urea, and
microperfusion experiments was approximately three 46.6 gluconate. FD&C green no. 3 dye (0.05%; Keystone,
Chicago, IL, USA) and bovine serum albumin (0.1%;weeks.
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Intergen, Purchase, NY, USA) were added to the perfu- Group 4 renal ablated rats, not acid loaded, had higher
sate, as was [3H]inulin (Mandel Canada, Guelph, On- plasma creatinine levels and hyperglycemia almost iden-
tario, Canada) to mark water reabsorption. Chloride was tical to group 1 diabetic rats. The plasma potassium con-
omitted from the perfusate to minimize bicarbonate se- centration was not different from group 5 (normal 1
cretion, permitting more careful assessment of the unidi- NH4Cl) rats. Neither hyperkalemia nor reduced rates of
rectional reabsorptive flux (Discussion section). The per- potassium excretion were present. Systemic acid-base
fused bicarbonate load of 300 pmol/min and [HCO3] 5 status and urine pH and bicarbonate excretion rates in
15 mmol/L was chosen to allow maximal reabsorptive these rats were essentially normal and entirely compara-
rates while reducing the transtubular bicarbonate gradi- ble to that observed in our laboratory in sham-operated
ent in acidotic rats. A 10-minute preperfusion period and nephrectomized nondiabetic rats [8].
preceded all collections. Sample collections were quanti-
Microperfusion studiestative and timed. Perfused tubules that provided samples
were back filled from the collection site with Latex (Mi- Table 3 and Figure 1 show the unidirectional DT bicar-
crofil; Flow Tech, Carver, MA, USA) to confirm surface bonate fluxes in the five groups. DTs from rats, with
direction of flow and to provide a hardened cast that, or without hyperglycemia, reabsorb bicarbonate briskly
when removed from the digested kidney, allowed mea- and not different from nondiabetic rats. Although the
surement of the length of the perfused segment. Whole means of fluxes are almost identical, the unusually small
blood, urine, and tubular fluid sample analyses were car- sem in group 2 elicited a statistically significant difference
ried as previously described [8]. Plasma renin activity (P , 0.05 by t-testing, but not analysis of variance) versus
(PRA) was estimated by a standard radioimmunoassay group 3. As previously described for nondiabetic rats
kit (NEN Life Science Products, Boston, MA, USA). [8], despite normal acid-base status and no acid loading,
Plasma aldosterone concentrations were determined by surviving DT from 2/3 Nx diabetic rats reabsorb bicar-
Cote A-Count Kit (TPC Diagnostic Corporation, Los bonate and water at high rates.
Angeles, CA, USA).
Statistical analyses were undertaken as previously de-
scribed [8]. DISCUSSION
The pathophysiology of metabolic acidosis in diabetic
patients has been well reviewed [1, 2] and the syndromeRESULTS
of hyporeninemic hypoaldosteronism, occurring in dia-Whole animal data
betics, has been the subject of several case reports and
Table 2 shows that in group 1 rats receiving once of speculation regarding tubular dysfunction [4, 9]. Al-
daily insulin, hyperglycemia and glycosuria were present though precise mechanisms underlying the acidifying de-
without ketosis, whereas in group 3, the insulin pump- fect remain unclear, it is likely that in those patients
implanted animals, blood glucose was tightly controlled
whose only derangement is a primary mineralocorticoid
and not different from normal levels. Furthermore,
deficiency, there will be reduced distal nephron protonblood and urine acid-base parameters were not different
secretion, with subsequent impairment of NH3 trapping,in groups 1, 2, 3, and 5, indicating a normal response
NH41 excretion, and net retention of H1 ions, causingto acid loading in both groups of diabetic rats without
metabolic acidosis [2]. However, a similar response coulddifferences in the severity of the metabolic acidosis.
result should there be a primary tubular defect in H1Plasma potassium concentrations were also not different
secretion in those many patients with the syndrome whoamong the groups. Finally, in separate groups of non–
have diabetic nephropathy and renal insufficiency.acid-loaded STZ diabetic, Nx, and control rats, PRA and
To assess distal nephron acidification in diabetic ratsplasma aldosterone concentrations were determined.
directly, we undertook in vivo microperfusion studies 18PRA (in ng/L/sec) in control rats was 12.93 6 0.80 (N 5
hours after acid loading and the induction of hyperchlor-5). PRA in two-week STZ diabetes was 6.84 6 0.89 (N 5
emic metabolic acidosis. Although these in vivo studies5). PRA in eight-week STZ diabetes was 12.25 6 1.50
could not assess segments of the nephron distal to the(N 5 7), and PRA in 2/3 NX plus two-week STZ diabetes
surface DT, our results demonstrate for the first timewas 4.96 6 0.56 (N 5 3). Two-week but not eight-week
that DT bicarbonate reabsorptive capacity is brisk andSTZ rats were significantly different from controls. Aldo-
not different from control rats and not influenced bysterone (in pmol/L) was also measured in four separate
hyperglycemia. We also show directly that DTs fromgroups of non–acid-loaded rats without significant differ-
ablated kidneys after STZ-induced diabetes enhanceences: control rats, 952 6 129 (N 5 5); two-week STZ
unidirectional bicarbonate reabsorption without aciddiabetes, 575 6 106 (N 5 5); eight-week STZ diabetes,
loading, comparable to fluxes measured in nondiabetic741 6 170 (N 5 7); 2/3 Nx plus two-week STZ diabetes,
507 6 228 (N 5 3). rats [8].
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Table 2. Balance, blood and urine data
Group 1 Group 2 Group 3 Group 4 Group 5
STZ1NH4Cl STZ1NH4Cl STZ1PUMP1NH4Cl STZ12/3 Nx Normal1NH4Cl
2 weeks 8 weeks 2 weeks 3 weeks
Balance
Food eaten g (3) 866 (5) 963 (4) 562 (5) 2162a,b,c,E (5) 1162
Drink consumed mL (5) 22613 (5) 61616 (4) 2366 (5) 8567a,c,e (5) 3167
Urine volume mL (5) 3969 (5) 81626 (4) 3266 (5) 67611E,C (5) 2366
LKW g (5) 1.3960.05 (5) 1.6860.06a (4) 1.2960.02b (5) 1.9060.11a,c,e (5) 1.0460.02a,b,C
LKW/BW % (5) 0.47860.004 (5) 0.46860.021 (4) 0.40060.004B (5) 0.61860.023 a,b,c,e (5) 0.38260.021a,b,C
Blood
pH (5) 7.2260.02 (5) 7.1660.03 (4) 7.1660.02 (5) 7.4160.01a,b,c,e (5) 7.2060.03
Pco2 mm Hg (5) 44.262.0 (5) 46.763.5 (4) 39.562.2 (5) 50.861.9A,C (5) 44.162.3
Plasma [HCO3] mmol (5) 18.461.7 (5) 17.061.9 (4) 14.361.2 (5) 32.460.8a,b,c,e (5) 17.461.1
Plasma [Na] mmol (5) 14263 (5) 13962.0 (4) 14361 (5) 14461 (5) 14461
Plasma [K] mmol (5) 3.560.2 (5) 3.560.2 (4) 3.460.2 (5) 4.360.3A,B,C (5) 4.060.2
Plasma [Cl] mmol (5) 11561 (5) 11062A (4) 12161a,b,e (5) 9861a,b,c,e (5) 11561b,c
Hematocrit % (5) 45.761.4 (5) 49.261.0 (4) 45.961.9 (5) 46.960.9 (5) 45.460.9B
Plasma [protein] g/dL (5) 5.560.1 (5) 6.360.1A,D (4) 6.060.3 (5) 5.760.2 (5) 5.860.1
Plasma [creatinine] lmol (4) 4761 (5) 55.663.8 (4) 5062 (5) 6863a,b,c,e (4) 4761
Glucose mmol (5) 16.461.9 (5) 20.062.6 (4) 4.761.1a,b (5) 15.961.4c,e (4) 5.260.7a,b
Systolic BP mm Hg (5) 15465 (5) 155612 (4) 17268 (5) 18464a (5) 157615
Urine
pH (5) 5.7460.05 (5) 5.860.05 (4) 5.6760.02 (5) 6.6760.04a,b,c,e (5) 5.6960.00
Specific gravity g/mL (5) 1.03360.002 (5) 1.03660.003 (4) 1.02560.004 (5) 1.04160.003c,E (5) 1.03060.003
Osmolality mOsm/kg H2O (5) 11886111 (5) 9666159 (4) 10506148 (5) 862667 (5) 12436155
Glucose mmol (5) 154653 (5) 212641 neg (5) 28060A neg
Ketones neg neg neg neg neg
HCO3 excretion lEq/18 h (5) 1364 (5) 34614 (4) 962 (5) 340667a,b,c,e (5) 661
Na excretion lEq/18 h (5) 18256140 (5) 28556612a (4) 23456160A (5) 16526189b,C (5) 21876447b
K excretion lEq/18 h (5) 40176454 (5) 51966780 (4) 36166204 (5) 46486333C,E (5) 29486344b
Cl excretion lEq/18 h (5) 91786682 (5) 1128761697 (4) 89206506 (5) 23096188a,b,c,E (5) 631361606c
Values are arithmetic means 6 sem of pooled data for each group (N). LKW/BW is left kidney wt as a percentage of total body weight.
aP , 0.05 vs. Group 1
bP , 0.05 vs. Group 2
cP , 0.05 vs. Group 3
eP , 0.05 vs. Group 5 (by one-way ANOVA)
AP , 0.05 vs. Group 1
BP , 0.05 vs. Group 2
CP , 0.05 vs. Group 3
DP , 0.05 vs. Group 4
EP , 0.05 vs. Group 5 (by t-test)
Table 3. Summary of microperfusion data
Collected Perfused
[Cl] [tCO2] JCl JHCO3Rats/ Tubule Perfusion JV nl
Group Procedure tubules length mm rate nl/min mmol min21 · mm21 pmol ·min21 ·mm21
1 STZ1NH4Cl (2 weeks) 5/6 1.2860.05 20.560.4 11.363.5 15.560.4 3.0160.41 2140654 76612
2 STZ1NH4Cl (8 weeks) 5/5 1.5660.11A 19.260.8 11.765.1 14.560.2 3.7960.48 2111656 7267
3 STZ1PUMP 1NH4Cl 4/5 1.3660.08 21.560.5 8.463.0 15.660.7 2.5660.68 2114643 9265B
4 STZ12/3 Nx 5/6 1.6060.09A 19.460.8 3.560.9E 15.160.8 5.4660.62a,c,e 22367E 83618
5 Normal1NH4Cl 5/6 1.4160.04 20.060.8 11.362.2 14.160.3 2.9060.18 2124627 7767
Values are arithmetic means 6 sem. aP , 0.05 vs. Group 1, cP , 0.05 vs. Group 4, eP , 0.05 vs. Group 5 (by one-way ANOVA)
A P , 0.05 vs. Group 1, BP , 0.05 vs. Group 2, EP , 0.05 vs. Group 5 (by t-test)
Streptozotocin diabetic rats with intact kidneys tion is minimized [10], permitting more careful assess-
ment of the unidirectional reabsorptive flux. In groups 1In an attempt to uncover small differences in acidifica-
and 2 diabetic acidotic rats, serum potassium, potassiumtion capacity, these microperfusion studies were de-
excretion rates, and hematocrit were not significantlysigned to test maximal bicarbonate reabsorption, and
different from each other or from the group 5 nondia-hence proton secretion by prior acid gavage and by per-
betic acidotic rats (Table 2). This indicates that neitherfusion of a bicarbonate load, which is much greater than
changes in extracellular fluid (ECF) volume, potassiumthat which normally enters the DT. Furthermore, by
omitting chloride from the perfusate, bicarbonate secre- homeostasis, or the degree of acidosis independently
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Fig. 1. (A) Blood glucose concentrations in
five experimental groups as described in Table
1 and the Methods section. (B) Corresponding
distal tubule unidirectional bicarbonate reab-
sorptive fluxes (JHCO3). Values are means 6
sem of N tubules. *P , 0.05 vs. groups 1, 2,
and 4 (by one-way ANOVA); †P , 0.05 vs.
group 3 (by t-test).
influenced the reabsorptive flux. In contrast, although therefore contribute to the increased net acid excretion
and to the defense of plasma bicarbonate concentration.our perfusate did not contain glucose, peritubular glu-
cose concentrations were undoubtedly high in group 1
Streptozotocin diabetic rats after 2/3 nephrectomyrats, simulating poorly controlled diabetes, in contrast
to the tight control achieved by insulin pump implanta- As noted previously in this article, renal insufficiency is
present in many of the reported cases of hyperchloremiction in group 3 rats. Still, DT bicarbonate reabsorptive
rates were not different from each other or from group metabolic acidosis in diabetic patients, making it reason-
able to speculate that an intrinsic tubular acidification5 rats.
In groups 1, 2, 3, and 5 at 18 hours after acid loading, defect may play a role in generating the acidosis, in
addition to the potential effects of hypoaldosteronismapproximate values for plasma bicarbonate concentra-
tions were 16 mmol/L for arterial blood, pH 7.19, and in suppressing tubular proton secretion and hyperka-
lemia in suppressing ammoniagenesis [1, 2]. In the pres-urine, pH 5.70, with no significant differences among
groups. This indicates that not only do diabetic rats nor- ent studies, we show surviving DTs after renal ablation
and STZ diabetes (group 4) reabsorbed bicarbonatemally acidify their urine, but also that whole kidney net
acid excretion was similar to nondiabetic rats, protecting briskly without the stimulus of an acid load or other
changes known to up-regulate proton secretion. Indeed,against the development of more severe metabolic acido-
sis. These results are also consistent with reported nor- the unidirectional bicarbonate flux of 83 pmol · min21 ·
mm21 is not different from the group 5 acid-loaded non-mal net acid excretion rates in 20-day STZ diabetic rats
not acid loaded, and their normal distal nephron acidifi- diabetic animals with intact kidneys and is similar to
remnant kidney data from our lab obtained with compa-cation assessed indirectly in the whole animal by urine
minus blood PCO2 measurements [11]. Still, our direct DT rable bicarbonate loads, but in the absence of diabetes
[8]. However, although these 2/3 Nx 1 STZ rats havebicarbonate flux measurements indicate that even after
the stress of acid loading, H1 secretory rates are brisk, higher urine pHs and higher bicarbonate excretion rates
when compared with the acid-loaded groups in this study,not different from that of nondiabetic rats, and must
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the data are entirely comparable to those from the sham- ACKNOWLEDGMENTS
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